期刊文献+

脑肽精对阿尔茨海默病模型大鼠的治疗作用 被引量:7

Remedial effects of brain peptide crystal on model rats with Alzheimer's disease
下载PDF
导出
摘要 目的 :观察脑肽精 (BPC)对阿尔茨海默病 (AD)大鼠学习记忆力的影响。方法 :雄性SD大鼠 84只 ,随机分成 7组 ,每组 1 2只。Ⅰ组为正常对照组 ,Ⅱ组为AD模型组 ,Ⅲ组为AD模型 +生理盐水组 ,Ⅳ组为AD模型 +脑复康 0 .3g/kg治疗组 ,Ⅴ组为AD模型 +BPC 1 5mg/kg治疗组 ,Ⅵ组为AD模型 +BPC 30mg/kg治疗组 ,Ⅶ组为AD模型 +BPC 6 0mg/kg治疗组。采用大鼠脑组织立体定位微量注射技术 ,用鹅膏蕈氨酸 (IBO)损毁大鼠双侧迈纳特基底核 (nbM)。手术后BPC连续灌胃 2 0d ,1次 /d ,每次 2ml。灌胃期满后即做迷宫实验及跳台实验以测学习、记忆能力。结果 :①与正常对照组比较 ,模型组的学习记忆能力均显著下降 (P <0 .0 1 ) ;②与模型组比较 ,生理盐水组无明显改变 (P >0 .0 5 ) ;③与模型组比较 ,脑复康组及BPC各浓度组的学习记忆能力均显著升高 (P <0 .0 1 )。结论 Aim:To observe the remedial effects of brain peptide crystal (BPC) on the animal model of non-hereditary Alzheimer's disease (AD). Methods: Eighty-four healthy male SD rats (8~12 weeks, 170~210 g) were randomly divided into 7 groups and each group contained 12 rats. The AD animal model was established by injecting IBO 1 μl (5 μg) into rats brain to damage bilateral nbM in rat brain. Group Ⅰ was normal group, group Ⅱ was AD animal model, group Ⅲ, Ⅳ,Ⅴ,Ⅵ and Ⅶ were AD animal model orally normal saline, Naofukang (0.3 g/kg·d), BPC (15 mg/kg·d), BPC (30 mg/kg·d), BPC (60 mg/kg·d), respectively. Group Ⅰ and group Ⅱ had not been treated. The experiment lasted for 20 days, the drugs were given once per day, and 2 ml for each time. The learning and remembering ability was tested by Y-maze test and jumping table experiment.Results: The learning and remembering ability of AD models decreased significantly( P <0.01).Comparing with group Ⅱ: the learning and remembering ability of group Ⅲ did not change significantly. Comparing with group Ⅱ: the learning and remembering ability of naofukang group and BPC groups increased significantly( P <0.01).Conclusion:PBC has good remedial effects on Aizheimer's disease.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2003年第6期884-886,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省杰出人才创新基金资助项目 0 2 10 0 0 5 0 0
关键词 脑肽精 阿尔茨海默病 大鼠 学习 记忆能力 brain peptide crystal Alzheimer's disease rat learning and remembering ability
  • 相关文献

参考文献8

二级参考文献37

  • 1高素荣 袁锦楣.痴呆诊疗学[M].北京:科学技术出版社,1988.90.
  • 2张豁中 温玉麟.动物活性成分化学[M].天津:天津科学技术出版社,1998.605.
  • 3[1]Cummings BJ, et al. The canine as an animal model of human aging and dementia[ J]. Neurobiol Aging, 1996; 17: 259-268
  • 4[2]Nelson PR, Saper CB. Injections of obadaic acid, but not beta-amyloid peptide, induce Alz-50 immunoreactive dystrophic neurites in the cerebral cortex of sheep[J]. Neurosci Lett, 1996;208:77-80
  • 5[3]Brion JP,et al. Transgenic expression of the shortest human tau affects its compartmentailization and its phosphorylation as in the pretangle stage of Alzheimer' s disease[J]. Am J Pathol, 1999; 154:255-70
  • 6[4]Lewis J, et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein[J]. Nature Genet,2000 ;25:402-405
  • 7[5]Nitta A, Nabeshima T. Experimental techiniques for developing new drugs acting on dementia: Alzheimer' s disease animal model induced by beta amyloid protein[ J]. Jap J Psychopharmacol, 1996; 16:85-90
  • 8[6]Cleary J, et al. β-amyloid (1-40)effects on behavior and memory. Brain Res, 1995 ;682:69-74
  • 9[7]Jeltsch H, et al. Lesins of supracallosal or infracallosal hippocampal pathways in the rat: behavioral, neurochemical and histochemical effects [J]. Behav Neural Biol, 1994;62:121-133
  • 10[8]Nag S, Tang F. Cholinergic lesions of the rat brain by ibotenic acid and 192 IgG-saporin: effects on somatostatin, substance P and neuropeptide Y levels in tle cerebral cortex and the hippocampus[ J]. Neurosci Lett, 1998;252:2,83-86

共引文献60

同被引文献98

引证文献7

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部